Table 3. HADS and SF-12 scores.
|
GP
|
Surgeon
|
Significance
|
||||||
|---|---|---|---|---|---|---|---|---|
| Outcome | n * | median | IQR | n * | median | IQR | unadjusteda | adjustedb |
| HADS anxiety | ||||||||
| Baseline | 95 | 4.0 | 5.0 | 106 | 4.0 | 4.0 | ||
| 12 months | 81 | 4.0 | 3.5 | 87 | 4.0 | 4.0 | 0.932 | 0.716 |
| 24 months | 76 | 4.0 | 5.0 | 81 | 5.0 | 4.5 | 0.440 | 0.106 |
| HADS depression | ||||||||
| Baseline | 97 | 4.0 | 5.0 | 106 | 3.0 | 4.0 | ||
| 12 months | 81 | 4.0 | 4.0 | 87 | 4.0 | 5.0 | 0.213 | 0.283 |
| 24 months | 76 | 4.0 | 5.0 | 81 | 3.0 | 4.0 | 0.540 | 0.796 |
| SF-12 PCS | ||||||||
| Baseline | 95 | 42.3 | 20.5 | 105 | 40.5 | 19.0 | ||
| 12 months | 82 | 49.3 | 11.2 | 88 | 55.9 | 14.3 | 0.576 | 0.887 |
| 24 months | 76 | 48.5 | 17.7 | 79 | 50.4 | 14.4 | 0.194 | 0.279 |
| SF-12 MCS | ||||||||
| Baseline | 95 | 55.0 | 12.9 | 105 | 55.1 | 14.5 | ||
| 12 months | 81 | 49.9 | 13.0 | 88 | 55.6 | 10.8 | 0.558 | 0.510 |
| 24 months | 74 | 54.4 | 11.8 | 79 | 55.9 | 11.2 | 0.448 | 0.474 |
Not all participants identified as ‘available for follow-up’ (Figure 1) completed every instrument.
Mann–Whitney U-test.
Adjusted for baseline value using analysis of covariance on ranks.